SV Health Investors — 2016 Investments
6 investments dated 2016 · listed companies and verified rows first · show all
Axon Therapies develops the SAVM procedure, an implant-free catheter-based ablation therapy that targets the right greater splanchnic nerve to reduce overactive sympathetic nerve activity in patients with heart failure with preserved ejection fraction (HFpEF).
HealthtechMedical DevicesNew York, US
Howard R. Levin(Executive Officer, Director)Mark Gelfand(Executive Officer)Zoar Engelman, PhD(President & CEO)Chad Hoskins(President & Chief Executive Officer)
Board seatPaul LaViolette· per SEC Form D · $2M raise · filed Apr 2016
Co-investorsStar51 CapitalAction Potential Venture Capital Ltd.Deerfield Management CompanyEarlybird Venture Capital
CardioFocus develops Pulsed Field Ablation (PFA) technologies and systems for electrophysiologists to treat complex cardiac arrhythmias with precision and control.
BiotechHealthtechMedical DevicesMarlborough, US
Lauren Jennings(Executive Officer)Warren Clark(Executive Officer)Stephen Sagon(Executive Officer, Director)inAnjie Roldan(Executive Officer)inWarren R. Clark III(Executive Officer)Stephan S. Ogilvie(CEO)in
Board seatPaul LaViolette· per SEC Form D
Co-investorsBioBritSaints CapitalAccuitive Medical VenturesOxford Bioscience PartnersSV Life Sciences
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)inAnthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)Sam R. Leno(Director)Leslie A. Saxon(Director)
Board seatPaul LaViolette· per SEC Form D
Co-investorsAPERTURE Venture PartnersBioventures InvestorsJumpstart VenturesLumira VenturesOSF VenturesSeroba Life Sciences+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Direct Flow MedicalAeroCare Holdings, Inc.Aligned Telehealth Inc
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








